Inactive

*******AMENDMENT 1***** The purpose of this Amendment is to extend the due date for quote submission. All quotes are due, electronically via email to Nina.Montgomery@fda.hhs.gov no later than August 3... *******AMENDMENT 1***** The purpose of this Amendment is to extend the due date for quote submission. All quotes are due, electronically via email to Nina.Montgomery@fda.hhs.gov no later than August 30, 2024 (10:00AM EST) Late submissions may not be evaluated.